Crewe Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2K Buy
124
+9
+8% +$1.66K ﹤0.01% 581
2026
Q1
$21.7K Sell
115
-13
-10% -$2.74K ﹤0.01% 505
2025
Q4
$25.4K Buy
128
+13
+11% +$2.63K ﹤0.01% 446
2025
Q3
$23.4K Buy
+115
New +$20.4K ﹤0.01% 469

Other funds holding THC

Crewe Advisors's THC Position: Q2 2026 in Review

Crewe Advisors increased its Tenet Healthcare (THC) stake by 7.8% in Q2 2026, buying an estimated $1.66K and bringing the position to 124 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Crewe Advisors first reported a position in THC in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.4K in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Crewe Advisors held 124 shares of Tenet Healthcare worth $23.2K as of Q2 2026.
  • Crewe Advisors bought 9 Tenet Healthcare shares in Q2 2026, an estimated $1.66K.
  • Tenet Healthcare made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #581 holding.
  • Crewe Advisors first reported a position in Tenet Healthcare in Q3 2025 and has held it in 4 quarters since.
  • Crewe Advisors's Tenet Healthcare position peaked at $25.4K in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.